Researchers accurately predict how well body will fight lung cancer based on patterns of immune cells

by Case Western Reserve UniversityActual photographs of the shape of the cancer-associated immune cells. Credit: Case Western Reserve UniversityResearchers at Case Western Reserve University have

Updated on: March 01,2024

Researchers accurately predict how well body will fight lung cancer based on patterns of immune cells

by Case Western Reserve UniversityActual photographs of the shape of the cancer-associated immune cells. Credit: Case Western Reserve UniversityResearchers at Case Western Reserve University have

Updated on:March 01,2024

Study of immune 'neighborhoods' highlights macrophages as key players in invasive breast cancers

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainMost immunotherapies, which aim to boost T cell activity, work poorly in treating estrogen receptor-positive (ER+) breast cancer. Targ

Updated on: January 02,2024

Study of immune 'neighborhoods' highlights macrophages as key players in invasive breast cancers

byUniversity of PittsburghCredit: Unsplash/CC0 Public DomainMost immunotherapies, which aim to boost T cell activity, work poorly in treating estrogen receptor-positive (ER+) breast cancer. Targ

Updated on:January 02,2024

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on: March 12,2024

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on:March 12,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A

Updated on: May 25,2024

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A

Updated on:May 25,2024

Target discovered for the treatment of pancreatic cancer

byKiel UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA team at the Institute of Biochemistry at Kiel University has found a

Updated on: July 05,2024

Target discovered for the treatment of pancreatic cancer

byKiel UniversityAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA team at the Institute of Biochemistry at Kiel University has found a

Updated on:July 05,2024

Combination therapy overcomes BET inhibitor resistance, shows study

bySt. Jude Children's Research HospitalStudy first author Shaela Fields (Wright), from the lab of Chunliang, Li, PhD, St. Jude Department of Tumor Cell Biology, led research to understand BE

Updated on: January 16,2024

Combination therapy overcomes BET inhibitor resistance, shows study

bySt. Jude Children's Research HospitalStudy first author Shaela Fields (Wright), from the lab of Chunliang, Li, PhD, St. Jude Department of Tumor Cell Biology, led research to understand BE

Updated on:January 16,2024

A new blood test could detect early stage melanoma in more than 80% of patients

by Mel Ziman,The ConversationCredit: AI-generated imageMelanoma killsmore than 1,700 Australians every year, which is more than thenational road toll. But the good news is it's t

Updated on: May 21,2024

A new blood test could detect early stage melanoma in more than 80% of patients

by Mel Ziman,The ConversationCredit: AI-generated imageMelanoma killsmore than 1,700 Australians every year, which is more than thenational road toll. But the good news is it's t

Updated on:May 21,2024

Team discovers broken 'brake' of cancer mutation machine

by UT Southwestern Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.010Loss of a gene known as SYNCRIP in prostate cancer tumors unleashes cellular machinery that

Updated on: February 03,2024

Team discovers broken 'brake' of cancer mutation machine

by UT Southwestern Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.010Loss of a gene known as SYNCRIP in prostate cancer tumors unleashes cellular machinery that

Updated on:February 03,2024

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

by Impact Journals LLCLung adenocarcinoma histochemistry. Representative sections illustrating tumor HA histochemistry staining (Ventana HA RxDx Assay) in FFPE lung adenocarcinoma samples scored as HA

Updated on: January 23,2024

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study

by Impact Journals LLCLung adenocarcinoma histochemistry. Representative sections illustrating tumor HA histochemistry staining (Ventana HA RxDx Assay) in FFPE lung adenocarcinoma samples scored as HA

Updated on:January 23,2024

Mouse study suggests new therapeutic strategy to reduce cardiovascular disease in cancer survivors

byRockefeller University PressA mouse model of cardiac toxicity following DNA damage. (A) Schematic representation of experimental model of radiation-induced cardiac toxicity and timeline cardio

Updated on: January 11,2024

Mouse study suggests new therapeutic strategy to reduce cardiovascular disease in cancer survivors

byRockefeller University PressA mouse model of cardiac toxicity following DNA damage. (A) Schematic representation of experimental model of radiation-induced cardiac toxicity and timeline cardio

Updated on:January 11,2024

Mutation analysis on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new research paper was published inOncotargetentitled, "Mutation analysis performed on tumor biopsies from patients with newly

Updated on: January 15,2024

Mutation analysis on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainA new research paper was published inOncotargetentitled, "Mutation analysis performed on tumor biopsies from patients with newly

Updated on:January 15,2024